This session answers questions about xenotransplantation and reviews current research on cross-species transplantations. Where the future may take us as we search for ways to support individuals in need of organ transplants is also explored.

Continuing Education Instructions and Disclosure Information:

Contact hours available until 5/25/24.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development (NCPD) evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.

Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):

Planning Committee Disclosures:
Christine Corbett, DNP, FNP-BC, CNN-NP, FNKF – Advisory Board Member for the National Kidney Foundation (NKF) and Speakers Bureau for GSK Anemia.

There are no other Planning Committee disclosures to declare.

Speaker Disclosures:
Douglas Anderson, MD - Sub-investigator on a research grant from United Therapeutics for xenotransplantation studies.

There are no other speaker disclosures to declare.

Commercial Support:
No commercial support declared.

Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.

ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.

Learning Outcome:
Upon completion of this activity, the learner will be able to discuss recent developments in the research and development of xenotransplant.

Credits Available